JPS6048484B2 - Diffusable activator dispenser - Google Patents
Diffusable activator dispenserInfo
- Publication number
- JPS6048484B2 JPS6048484B2 JP6704280A JP6704280A JPS6048484B2 JP S6048484 B2 JPS6048484 B2 JP S6048484B2 JP 6704280 A JP6704280 A JP 6704280A JP 6704280 A JP6704280 A JP 6704280A JP S6048484 B2 JPS6048484 B2 JP S6048484B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- dispenser
- active agent
- core
- compartment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000012190 activator Substances 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000013543 active substance Substances 0.000 claims description 25
- 229920000642 polymer Polymers 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 24
- 239000011148 porous material Substances 0.000 claims description 13
- 239000012528 membrane Substances 0.000 claims description 10
- 230000003204 osmotic effect Effects 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 7
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- -1 aryl phosphates Chemical class 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 8
- 229920002301 cellulose acetate Polymers 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 239000000017 hydrogel Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 3
- MQHNKCZKNAJROC-UHFFFAOYSA-N dipropyl phthalate Chemical compound CCCOC(=O)C1=CC=CC=C1C(=O)OCCC MQHNKCZKNAJROC-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 150000007514 bases Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- IPKKHRVROFYTEK-UHFFFAOYSA-N dipentyl phthalate Chemical compound CCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCC IPKKHRVROFYTEK-UHFFFAOYSA-N 0.000 description 2
- ICJBPZBRDLONIF-UHFFFAOYSA-N hexane-1,1,1,2,2,3-hexol Chemical compound CCCC(O)C(O)(O)C(O)(O)O ICJBPZBRDLONIF-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229960003253 procainamide hydrochloride Drugs 0.000 description 2
- ABTXGJFUQRCPNH-UHFFFAOYSA-N procainamide hydrochloride Chemical compound [H+].[Cl-].CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 ABTXGJFUQRCPNH-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- JWXJLTQZSYKXIP-UHFFFAOYSA-N 2,3-diacetyloxypropyl 2-hydroxypropanoate Chemical compound CC(O)C(=O)OCC(OC(C)=O)COC(C)=O JWXJLTQZSYKXIP-UHFFFAOYSA-N 0.000 description 1
- YEVQZPWSVWZAOB-UHFFFAOYSA-N 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(I)C(CBr)=C1 YEVQZPWSVWZAOB-UHFFFAOYSA-N 0.000 description 1
- OVOUKWFJRHALDD-UHFFFAOYSA-N 2-[2-(2-acetyloxyethoxy)ethoxy]ethyl acetate Chemical compound CC(=O)OCCOCCOCCOC(C)=O OVOUKWFJRHALDD-UHFFFAOYSA-N 0.000 description 1
- AJMJPGWUPHIMKQ-UHFFFAOYSA-N 2-[2-(2-butanoyloxyethoxy)ethoxy]ethyl butanoate Chemical compound CCCC(=O)OCCOCCOCCOC(=O)CCC AJMJPGWUPHIMKQ-UHFFFAOYSA-N 0.000 description 1
- AWKXKNCCQLNZDB-UHFFFAOYSA-N 2-[2-(2-propanoyloxyethoxy)ethoxy]ethyl propanoate Chemical compound CCC(=O)OCCOCCOCCOC(=O)CC AWKXKNCCQLNZDB-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- SFTRWCBAYKQWCS-UHFFFAOYSA-N 2-butanoyloxyethyl butanoate Chemical compound CCCC(=O)OCCOC(=O)CCC SFTRWCBAYKQWCS-UHFFFAOYSA-N 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- YJERZJLSXBRUDQ-UHFFFAOYSA-N 2-o-(3,4-dihydroxybutyl) 1-o-methyl benzene-1,2-dicarboxylate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OCCC(O)CO YJERZJLSXBRUDQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GOJCZVPJCKEBQV-UHFFFAOYSA-N Butyl phthalyl butylglycolate Chemical compound CCCCOC(=O)COC(=O)C1=CC=CC=C1C(=O)OCCCC GOJCZVPJCKEBQV-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920001747 Cellulose diacetate Polymers 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- YUXIBTJKHLUKBD-UHFFFAOYSA-N Dibutyl succinate Chemical compound CCCCOC(=O)CCC(=O)OCCCC YUXIBTJKHLUKBD-UHFFFAOYSA-N 0.000 description 1
- VIZORQUEIQEFRT-UHFFFAOYSA-N Diethyl adipate Chemical compound CCOC(=O)CCCCC(=O)OCC VIZORQUEIQEFRT-UHFFFAOYSA-N 0.000 description 1
- DKMROQRQHGEIOW-UHFFFAOYSA-N Diethyl succinate Chemical compound CCOC(=O)CCC(=O)OCC DKMROQRQHGEIOW-UHFFFAOYSA-N 0.000 description 1
- QWDBCIAVABMJPP-UHFFFAOYSA-N Diisopropyl phthalate Chemical compound CC(C)OC(=O)C1=CC=CC=C1C(=O)OC(C)C QWDBCIAVABMJPP-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- UXDDRFCJKNROTO-UHFFFAOYSA-N Glycerol 1,2-diacetate Chemical compound CC(=O)OCC(CO)OC(C)=O UXDDRFCJKNROTO-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- PCYQQSKDZQTOQG-NXEZZACHSA-N dibutyl (2r,3r)-2,3-dihydroxybutanedioate Chemical compound CCCCOC(=O)[C@H](O)[C@@H](O)C(=O)OCCCC PCYQQSKDZQTOQG-NXEZZACHSA-N 0.000 description 1
- 229960002097 dibutylsuccinate Drugs 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- YSAVZVORKRDODB-WDSKDSINSA-N diethyl tartrate Chemical compound CCOC(=O)[C@@H](O)[C@H](O)C(=O)OCC YSAVZVORKRDODB-WDSKDSINSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 1
- 229960001826 dimethylphthalate Drugs 0.000 description 1
- VNTXONBESJNLBI-UHFFFAOYSA-N dinonyl decanedioate Chemical compound CCCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCCC VNTXONBESJNLBI-UHFFFAOYSA-N 0.000 description 1
- RLRMXWDXPLINPJ-UHFFFAOYSA-N dioctan-2-yl benzene-1,2-dicarboxylate Chemical compound CCCCCCC(C)OC(=O)C1=CC=CC=C1C(=O)OC(C)CCCCCC RLRMXWDXPLINPJ-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- UHGPEWTZABDZCE-UHFFFAOYSA-N dipropyl decanedioate Chemical compound CCCOC(=O)CCCCCCCCC(=O)OCCC UHGPEWTZABDZCE-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 description 1
- 239000012229 microporous material Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000016337 monopotassium tartrate Nutrition 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 229920001390 poly(hydroxyalkylmethacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 1
- 229940081543 potassium bitartrate Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 229960000244 procainamide Drugs 0.000 description 1
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
【発明の詳細な説明】
本発明は拡散性活性剤ディスペンサーの改良にあり、
特に活性剤が薬品であつて、水がディスペンサー中に微
孔質壁を通して拡散し、溶液の形の活性剤が微孔質壁を
通してディスペンサーの外に拡散する拡散メカニズムに
より作動する活性剤ディスペンサーの改良にある。DETAILED DESCRIPTION OF THE INVENTION The present invention is an improvement in a diffusible active agent dispenser;
Improvements in active agent dispensers, especially where the active agent is a drug and which operate by a diffusion mechanism in which water diffuses into the dispenser through the microporous walls and the active agent in solution form diffuses out of the dispenser through the microporous walls. It is in.
本発明の水性環境ての使用を意図した拡散性活性剤デ
ィスペンサーに関し、本発明のディスペンサーは膨潤し
、多孔質になつて水が芯に到達し、そして活性剤組成物
を溶解せしめる重合体の被覆物または壁により取り囲ま
れている水溶性活性剤組成物の内部芯よりなる。With respect to the diffusible active agent dispensers of the present invention intended for use in aqueous environments, the dispensers of the present invention are coated with a polymer that swells and becomes porous allowing water to reach the core and dissolve the active agent composition. It consists of an inner core of water-soluble active agent composition surrounded by a material or wall.
生じる活性剤の溶液は壁の孔を通してディスペンサーの
外に拡散する。 溶液が活性剤で飽和されているかぎり
、活性剤の放出速度は実質的に一定である。活性剤がデ
ィスペンサーから放出されるにつれて、溶液中の活性剤
濃度は最終的に飽和以下に降下する。この現象が1度生
起すると、放出速度は一次動力(flrstorder
kinetics)に従い、低下しはじめる。 本発明
の目的は芯中の活性剤の溶液が飽和状態にとどまる時間
を延長させ、かくして放出速度が実質的に一定である時
間を延長させることにある。 本発明は内部隔室を定め
る外側の微孔質壁および隔室内に含有された水溶性活性
剤組成物よりなり、この隔室がまた水の吸収に応答して
膨張する少なくとも1種の膨張性部材を含有することを
特徴とする錠剤物の拡散性活性剤ディスペンサーにあり
、かかる部材は滲透圧作用性溶質の芯、ガス発生性カッ
プル(couple)または水膨潤性重合体とこの芯を
取り囲んでいる膨張性の半透過性膜よりなるものである
。The resulting solution of active agent diffuses out of the dispenser through holes in the wall. As long as the solution is saturated with active agent, the rate of active agent release is substantially constant. As the active agent is released from the dispenser, the active agent concentration in the solution eventually drops below saturation. Once this phenomenon occurs, the release rate will change depending on the primary force (flrstorder
kinetics) and begin to decline. It is an object of the present invention to prolong the time during which the solution of active agent in the core remains saturated, thus prolonging the time during which the release rate is substantially constant. The present invention comprises an outer microporous wall defining an internal compartment and a water-soluble active agent composition contained within the compartment, the compartment also having at least one swellable material that swells in response to absorption of water. A dispersible active agent dispenser in the form of a tablet, characterized in that it contains a core of osmotic solute, a gas-generating couple or a water-swellable polymer and surrounding said core. It consists of an expandable semi-permeable membrane.
1 作動させるには、このディスペンサーを水性環境下
におくと、周辺からの水が微孔質壁の孔を通して内部隔
室中に拡散し、ここて水が活性剤組成物を溶解してその
飽和溶液を生成する。1 To operate, the dispenser is placed in an aqueous environment and water from the surroundings diffuses through the pores of the microporous wall into the internal compartment where the water dissolves the active agent composition and saturates it. Produce a solution.
生成する溶液は孔を通してディスペンサーの外に拡散す
・る。同時に、隔室内の水は部材の半透過性壁を通つて
膨潤性膜中に吸収される。この部材は、部材芯が滲透圧
作用性溶質から作られていると、静水圧の力で吸収され
た水に応答して膨張し、部材芯が水膨潤性重合体から作
られていると、膨潤し、そして部材芯がガス発生性カッ
プルから作られていると、空気圧により膨張する。この
部材による水の吸収は活性剤組成物の溶解に利用できる
水の量を減じ、また部材の膨張は活性剤組成物の溶液に
より占められる隔室の容積を減じる。この結果、飽和状
態がより長い時間の間、維持される。図面において:
)第1図は温血動物に薬剤を経口投与するための錠剤の
形のディスペンサーの拡大透視図である;第2図は第1
図のディスペンサーの作動時の部品配列を示す断面図で
ある;そして第3図は第1図のディスペンサーの時間に
対する理論的放出速度を従来技術のディスペンサーから
の薬品の時間に対する理論的放出速度と比較して示すグ
ラフである。The resulting solution diffuses out of the dispenser through the holes. At the same time, water within the compartment is absorbed into the swellable membrane through the semi-permeable wall of the member. The member expands in response to absorbed water under hydrostatic forces if the member core is made from an osmotic solute, and if the member core is made from a water-swellable polymer. Swells and, if the member core is made of gas-generating couples, expands due to air pressure. Absorption of water by the member reduces the amount of water available for dissolving the active agent composition, and expansion of the member reduces the volume of the compartment occupied by the solution of the active agent composition. As a result, saturation is maintained for a longer period of time. In the drawing:
) FIG. 1 is an enlarged perspective view of a tablet-shaped dispenser for oral administration of drugs to warm-blooded animals;
3 is a cross-sectional view showing the arrangement of parts during operation of the dispenser of FIG. 1; and FIG. 3 compares the theoretical release rate versus time of the dispenser of FIG. 1 with the theoretical release rate versus time of drug from a prior art dispenser. This is a graph shown as follows.
第1および2図は一般的に10で示されている錠剤の形
のディスペンサーを示している。ディスペンサー1口は
その外側が複数の孔16(これは例示のために円形であ
るように描いてある)を有する形状保持性壁12により
定められており、内部隔室13を包有している本体11
よりなる。隔室13は水溶性薬品組成物および膨張性部
材15を含有する。部材15は滲透圧作用性溶質組成物
、水膨潤性重合体またはガス発生カップルの内部芯18
を包む外側の膨張性半透過性部材15よりなる。ディス
ペンサーは1度、膨張すると次のように.作動する。Figures 1 and 2 show a tablet-shaped dispenser, generally indicated at 10. The dispenser mouth is defined on the outside by a shape-retaining wall 12 having a plurality of holes 16 (which are depicted as circular for illustrative purposes) and encloses an interior compartment 13. Main body 11
It becomes more. Compartment 13 contains a water-soluble drug composition and an inflatable member 15. The member 15 is an osmotic solute composition, a water-swellable polymer, or an inner core 18 of a gas-generating couple.
It consists of an outer inflatable semi-permeable member 15 enclosing. Once the dispenser is inflated, it looks like this: Operate.
胃腸器管からの水が壁12の孔16を通つてディスペン
サー中に拡散し、組成物14を溶解させる。組成物14
は第2図では溶液の形で示されている。溶液の形になる
と、組成物14は胃腸器管中に孔16を通つて外側に拡
散する。ま.た、水がディスペンサー中に存在すると、
部材15が活性になる。組成物14の溶液からの水は半
透過性膜17を通つて拡散し、芯18に達する。芯18
が滲透圧作用性溶質からなる場合には、水が溶質を溶解
し、滲透圧幻配が組成物14の溶液・と溶質溶液との間
に膜17を通して確立される。この結果、膜17を通し
て部材15により多くの水が吸収される。生じる水圧が
部材15を膨張させる。芯18が水膨潤性重合体から構
成されている場合には、水が重合体を膨潤させ、かくし
て部材15が膨張する。芯18がガス発生性カップルか
ら構成されている場合には、水がカップルと反応して、
ガスを発生する。生じる空気圧が部材15を膨張させる
。部材15が水を吸収すると、組成物14の溶液の水含
有量が減少する。そして、部材15が膨張すると、組成
物14の溶液により占領されうる隔室13内の容積が減
少する。この組合された作用の正味の結果として、組成
物14の溶液の飽和状態が保持され、かくして単位活性
度が維持される。第3図は第1図のディスペンサーから
の時間に対する薬品放出速度(点線DEF)を膨張性部
材15を含まない類似のディスペンサーの場合(実線A
BC)と比較して例示するものてある。Water from the gastrointestinal tract diffuses into the dispenser through holes 16 in wall 12 and dissolves composition 14. Composition 14
is shown in solution form in FIG. Once in solution form, composition 14 diffuses outward through pores 16 into the gastrointestinal tract. Ma. Also, if water is present in the dispenser,
Member 15 becomes active. Water from the solution of composition 14 diffuses through semipermeable membrane 17 and reaches wick 18 . Core 18
If the solute is comprised of an osmotic solute, the water dissolves the solute and an osmotic barrier is established through the membrane 17 between the solution of composition 14 and the solute solution. As a result, more water is absorbed by the member 15 through the membrane 17. The resulting water pressure causes member 15 to expand. If the core 18 is comprised of a water-swellable polymer, the water will swell the polymer and thus the member 15 will expand. If the wick 18 is comprised of a gas-generating couple, water reacts with the couple and
Generates gas. The resulting air pressure causes member 15 to expand. As member 15 absorbs water, the water content of the solution of composition 14 decreases. As member 15 expands, the volume within compartment 13 that can be occupied by the solution of composition 14 decreases. The net result of this combined action is to maintain the saturation of the solution of composition 14, thus maintaining unit activity. FIG. 3 shows the drug release rate versus time (dotted line DEF) from the dispenser of FIG. 1 for a similar dispenser without inflatable member 15 (solid line A).
BC).
図示されているように、一定の放出速度が時間Bから時
間Eまで延長されており、一定値から空になるまでの傾
斜は第1図のディスペンサーの場合により急速である。
壁12を形成する微孔質物質はディスペンサーが作動し
ているときに、相互連結した複数の微孔質または気孔を
有する。As shown, the constant release rate is extended from time B to time E, and the ramp from constant to empty is more rapid for the dispenser of FIG.
The microporous material forming wall 12 has a plurality of interconnected micropores or pores when the dispenser is in operation.
孔は一般にこの材料の容積5%ないし95%を占めてお
り、50オングストロームないし100ミクロンの寸法
を有する。孔は材料に予め形成しておいてもよく、また
は胃腸器管内でその場で形成させてもよい。このような
材料の製造に使用できる重合体および孔の形成技術は良
く知られている。孔の前形成技術の例には重合体を原子
トラッキングにより溶蝕し、重合体溶液を冷却させて重
合体中に溶媒結晶を形成させ、次いて重合体を硬化させ
て結晶を除去し、重合体フィルムに延伸し、次に重合体
から可溶性成分を浸出させる方法がある。孔はまた、膨
潤し、多孔質になる重合体または重合体から溶出または
浸出する水溶性の孔形成性成分を含む重合体を使用し、
そこに孔を生成させる方法によりその場て形成してもよ
い。壁12用に使用できる重合体の例は米国特許第41
6045訝に記載されている。膜17の製造に使用でき
る半透過性重合体は水に対し透過性てあつて、隔室13
および部材15のその他の成分に対して実質的に不透過
性である。このような重合体の例には、セルロースアセ
テート、セルロースジアセテート、セルローストリアセ
テート、ジメチルセルロースアセテート、セルロースア
セテート、エチルカーボネート、およびぞの他のセルロ
ースエーテルおよびエーテルがある。膜17に可撓性お
よび膨張性を付与するために、半透過性重合体に1種ま
たは2種以上の可塑剤を加えることが望ましい。このよ
うな可塑剤の例には、フタル酸ジメチル、フタル酸ジプ
ロピル、フタル酸ジ(2−エチルヘキシル)、フタル酸
ジイソプロピル、フタル酸ジアミルおよびフタル酸ジカ
プリル;リン酸トリブチル、リン酸トリオクチル、リン
酸トリクレシルおよびリン酸トリフェニルのごときアル
キルおよびアリールリン酸エステル;フェン酸トリブチ
ル、クエン酸トリエチルおよびトリエチルクエン酸アセ
チルのごときクエン酸アルキルエステル;アジピン酸ジ
オクチル、アジピン酸ジエチルおよびアジピン酸ジ(2
−メトキシエチル)のごときアジピン酸アルキルエステ
ル;酒石酸ジエチルおよび酒石酸ジブチルのごとき酒石
酸ジアルキル;セバシン酸ジエチル、セバシン酸ジプロ
ピルおよびセバシン酸ジノニルのごときセバシン酸アル
キル;コハク酸ジーエチルおよびコハク酸ジブチルのご
ときコハク酸アルキル;グリセロールジアセテート、グ
リセロールトリアセテート、グリセロールモノラクテー
トジアセテート、メチルフタリルエチルグリコレート、
ブチルフタリルブチルグリコレート、エチ’レングリコ
ールジアセテート、エチレングリコールジアブチレート
、トリエチレングリコールジアセテート、トリエチレン
グリコールジブチレートおよびトリエチレングリコール
ジプロピオネートのこときグリコール酸アルキル、グリ
セロール酸アルキル、グリコールエステルおよびグリセ
ロールエステルがある。部材15に使用できる滲透圧作
用性溶質は溶液中で高い滲透圧を示す有機および無機化
合物を包含する。The pores generally occupy 5% to 95% of the volume of the material and have dimensions of 50 angstroms to 100 microns. The pores may be preformed in the material or may be formed in situ within the gastrointestinal tract. Polymers and pore formation techniques that can be used to make such materials are well known. Examples of pore pre-formation techniques include etching the polymer by atomic tracking, cooling the polymer solution to form solvent crystals in the polymer, and then curing the polymer to remove the crystals. One method is to stretch the film and then leach the soluble components from the polymer. The pores also use a polymer that swells and becomes porous or contains a water-soluble pore-forming component that is leached or leached from the polymer;
It may be formed in-situ by a method of creating holes there. Examples of polymers that can be used for wall 12 are U.S. Pat.
It is described in 6045. The semi-permeable polymer that can be used to make the membrane 17 is permeable to water so that the compartment 13
and substantially impermeable to other components of member 15. Examples of such polymers include cellulose acetate, cellulose diacetate, cellulose triacetate, dimethylcellulose acetate, cellulose acetate, ethyl carbonate, and other cellulose ethers and ethers. It may be desirable to add one or more plasticizers to the semipermeable polymer to impart flexibility and swellability to membrane 17. Examples of such plasticizers include dimethyl phthalate, dipropyl phthalate, di(2-ethylhexyl) phthalate, diisopropyl phthalate, diamyl phthalate and dicapryl phthalate; tributyl phosphate, trioctyl phosphate, tricresyl phosphate. and alkyl and aryl phosphates such as triphenyl phosphate; citric acid alkyl esters such as tributyl phenate, triethyl citrate and acetyl triethyl citrate; dioctyl adipate, diethyl adipate and di(2
- methoxyethyl); dialkyl tartrate such as diethyl tartrate and dibutyl tartrate; alkyl sebacate such as diethyl sebacate, dipropyl sebacate and dinonyl sebacate; alkyl succinate such as diethyl succinate and dibutyl succinate. ; Glycerol diacetate, glycerol triacetate, glycerol monolactate diacetate, methyl phthalylethyl glycolate,
Butylphthalyl butyl glycolate, ethylene glycol diacetate, ethylene glycol dibutyrate, triethylene glycol diacetate, triethylene glycol dibutyrate and triethylene glycol dipropionate, alkyl glycolate, alkyl glycerol, glycol There are esters and glycerol esters. Osmotic solutes that can be used in member 15 include organic and inorganic compounds that exhibit high osmotic pressures in solution.
このような溶質は硫酸マグネシウム、塩化マグネシウム
、塩化ナトリウム、塩化リチウム、硫酸カリウム、炭酸
ナトリウム、酸性リン酸カリウム、マニトール、尿素、
シヨ糖等を包含する。その他の滲透圧作用性溶質は米国
特許第385477吟および同第4077407号に記
載されていJる。部材15に使用できる膨潤性重合体は
水の存在下に溶解することなく高度に膨潤する、一般に
5−5晧の容積増加を示す、軽く交叉結合した親水性ヒ
ドロゲルである。Such solutes include magnesium sulfate, magnesium chloride, sodium chloride, lithium chloride, potassium sulfate, sodium carbonate, potassium acid phosphate, mannitol, urea,
Includes sucrose, etc. Other osmotic solutes are described in US Pat. No. 3,854,77 and US Pat. No. 4,077,407. Swellable polymers that can be used for member 15 are lightly cross-linked hydrophilic hydrogels that swell to a high degree in the presence of water without dissolving, typically exhibiting a 5-5 volume increase.
代表的なヒドロゲルはポリ(ヒドロキシアルキルメタア
クリレート)、ポリ(アクリルアミド)、ポリ (メタ
アクリルアミド)、ポリ (N−ビニルー2−ピロリド
ン)、陰イオン性および陽イオン性ヒドロゲル、高分子
電解質複合体、共重合体中の無水マレイン酸1モル当り
約0.001ないし約0。5モルの多不飽和交叉結合剤
で交叉結合した無水マレイン酸とスチレン、エチレン、
プロピレン、ブチレンまたはイソブチレンとの共重合体
の微粉の分散液を形成することにより生成される水不溶
性で水膨潤性の共重合体、N−ビニルラクタムの水膨潤
性重合体、半固体の交叉結合したポリ (ビニルピロリ
ドン)、ジエステル交叉結合したポリグルカンヒドロゲ
ルおよび複素環式N−ビニル単量体の陰イオン性ヒドロ
ゲルを包含する。Typical hydrogels include poly(hydroxyalkyl methacrylate), poly(acrylamide), poly(methacrylamide), poly(N-vinyl-2-pyrrolidone), anionic and cationic hydrogels, polyelectrolyte complexes, and polyelectrolyte complexes. Maleic anhydride and styrene, ethylene, crosslinked with about 0.001 to about 0.5 mole of polyunsaturated crosslinker per mole of maleic anhydride in the polymer.
Water-insoluble, water-swellable copolymers produced by forming a finely divided dispersion of copolymers with propylene, butylene or isobutylene, water-swellable polymers of N-vinyl lactam, semisolid cross-linking poly(vinylpyrrolidone), diester crosslinked polyglucan hydrogels, and anionic hydrogels of heterocyclic N-vinyl monomers.
部材15に使用できるガス発生性カップルは水の存在下
に溶解し、反応して、二酸化炭素を生成する固体の酸化
合物および塩基性化合物よりなる。Gas-generating couples that can be used in member 15 consist of solid acid and basic compounds that dissolve in the presence of water and react to produce carbon dioxide.
酸化合物はリンゴ酸、フマール酸、酒石酸、メタコン酸
、マレイン酸、クエン酸、アジピン酸、コハク酸および
メサコン酸のごとき有機酸並びにスルファミン酸または
リン酸のごとき無桟酸およびクエン酸マグネシウム、酸
性酒石酸カリウムおよび重酒石酸カリウムのごとき酸塩
を包含する。塩基性化合物は炭酸および重炭酸金属塩、
たとえば炭酸および重炭酸アルカリ塩を包含する。代表
的物質は炭酸および重炭酸リチウム、ナトリウムおよび
カリウム塩並びにアルカリ土類化合物、たとえば炭酸お
よび重炭酸カルシウム塩を包含する。1対の酸と塩基と
は実質的に化学量論的割合であることが好ましい。Acid compounds include organic acids such as malic acid, fumaric acid, tartaric acid, methaconic acid, maleic acid, citric acid, adipic acid, succinic acid and mesaconic acid, as well as non-carboxylic acids such as sulfamic acid or phosphoric acid and magnesium citrate, acidic tartaric acid. Includes acid salts such as potassium and potassium bitartrate. Basic compounds are carbonate and bicarbonate metal salts,
Examples include alkali carbonates and bicarbonates. Representative materials include lithium carbonate and bicarbonate, sodium and potassium salts and alkaline earth compounds such as calcium carbonate and bicarbonate salts. Preferably, the pair of acids and bases are in substantially stoichiometric proportions.
ディスペンサーは標準的方法に従い戴造てきる。Dispensers are manufactured according to standard methods.
たとえば、部材15を先ず、滲透性溶質、ガス発生カッ
プルまたは膨潤性重合体を半透過性重合体フィルムで包
み、次に水溶性活性剤組成物14を部材15に被覆また
は圧着させることにより作る。次に形成された組立物に
膜12を成形、噴霧、空気懸濁(Airsuspens
iOn)または浸漬により適用する。もう1つの方法で
は、壁12を先ず注形し、次に開口容器の形にし、ここ
に活性剤組成物14および部材15を充たし、次に閉じ
て、密封する。次例は本発明をさらに説明するものであ
る。For example, member 15 is made by first wrapping the permeable solute, gas-generating couple, or swellable polymer in a semi-permeable polymeric film and then coating or crimping the water-soluble active agent composition 14 onto member 15. Membrane 12 is then molded, sprayed, or air suspended onto the formed assembly.
iOn) or by dipping. In another method, wall 12 is first cast, then shaped into an open container, filled with active agent composition 14 and member 15, and then closed and sealed. The following examples further illustrate the invention.
これらの例は本発明の範囲をいずれの点でも限定しよう
とするものではない。別記しないかぎり、パーセントお
よび割合は重量による。例1
先ず、塩化ナトリウム125mgを圧縮し、次に圧縮さ
れた塩化ナトリウムを空気懸濁機においてアセチル含有
量32%のセルロースアセテート70%を塩化メチレン
−メタノール(80:2喀量割合)に溶解した分子量4
00のポリエチレングリコール30%と混合した組成物
で膨張性フィルムが膜上に形成されるまて被覆し、膨張
性部材を作る。These examples are not intended to limit the scope of the invention in any way. Percentages and proportions are by weight unless otherwise specified. Example 1 First, 125 mg of sodium chloride was compressed, and then the compressed sodium chloride was dissolved in methylene chloride-methanol (80:2 methanol ratio) with 70% cellulose acetate with an acetyl content of 32% in an air suspension machine. Molecular weight 4
00 mixed with 30% polyethylene glycol until an intumescent film is formed on the membrane and coated to form an intumescent member.
次に、乾燥プロカインアミド235m9をこの部材と混
合し、混合物を圧縮する。Next, 235 m9 of dry procainamide is mixed with this part and the mixture is compressed.
この圧縮された混合物を次に空気懸濁機において、アセ
チル含有量32%を有するセルロースアセテート65ダ
、ヘキサンヘキソール41y)ポリエチレングリコール
40011.7ダおよびアセトン19m1と水375m
1よりなる溶媒よりなる組成物で被覆する。被覆物は1
75ミクロンの厚さであり、このディスペンサーが胃腸
器管内におかれると、孔形成性ヘキサンヘキソールが被
覆物壁から浸出して50オングストローム〜100ミク
ロンの平均寸法の直径を有する孔が形成される。例2
先ず、炭酸水素カリウム56.7%、クエン酸40.2
%および無水ケイ酸マグネシウム3%の混合物を圧縮し
、次にこの混台物を空気懸濁機において、分子量400
のポリエチレングリコール10重量%が均質に分散され
ているアセチル含有量32%のセルロースアセテート9
0%よりなるフィルムで被覆す.る。This compressed mixture is then mixed in an air suspension with 65 m of cellulose acetate with an acetyl content of 32%, 41 y of hexanehexol, 11.7 m of polyethylene glycol 400 and 19 ml of acetone and 375 m of water.
1 and coated with a composition consisting of a solvent. The covering is 1
75 microns thick, and when the dispenser is placed in the gastrointestinal tract, the pore-forming hexanehexol leaches from the coating wall to form pores having a diameter with an average size of 50 angstroms to 100 microns. . Example 2 First, potassium hydrogen carbonate 56.7%, citric acid 40.2%
% and 3% anhydrous magnesium silicate, the mixture was then compressed in an air suspension to obtain a molecular weight of 400
Cellulose acetate 9 with an acetyl content of 32% in which 10% by weight of polyethylene glycol is homogeneously dispersed.
Cover with a film consisting of 0%. Ru.
被回操作は80:20(容量)の塩化メチレン−メタノ
ールよりなる溶媒を用いて行なう。次に、この部材をマ
ネステイ機(Manestymachlne)て圧縮に
より塩化カリウム500m9て包囲し、ポリ(塩化ビニ
ル)の微孔質壁を、孔形成.剤としてポリ 〔p−ジメ
チルアミノースチレン〕を含有するポリ(塩化ビニル)
よりなる重合体のシートを浸出することにより形成する
。The recirculation operation is carried out using a solvent consisting of 80:20 (by volume) methylene chloride-methanol. The part is then surrounded by 500 m9 of potassium chloride by compression in a Manesty machine to form a pore-forming poly(vinyl chloride) microporous wall. Poly(vinyl chloride) containing poly[p-dimethylaminose styrene] as an agent
Formed by leaching a sheet of polymer consisting of:
壁はシクロヘキサン溶液から注形し、溶媒を蒸発させる
ことにより形成する。次に、孔形成剤の浸出に塩酸の酸
性水溶液を使用し、微孔質壁を形成する。浸出は室温で
行ない、次いで蒸留水で洗浄して、酸を除去し、50オ
ングストローム〜100ミクロンの平均寸法の孔を有す
る微孔質壁を生成させる。例3プロカインアミド塩酸塩
を温血動物の胃腸器管に投与するための錠剤の形のディ
スペンサーを次のとおりにして作る:先ず、軽く交叉結
合した膨潤性ポリ (ヒドロキシアルキル)メタアクリ
レート200m9を、空気懸濁機において80:20(
容量)の塩化メチレン−メタノールに溶解した分子量4
00のポリエチレングリコール30%と混合したアセチ
ル含有量32%のセルロースアセテート70%よりなる
組成物で被覆し、重合体を包む。The walls are formed by casting from a cyclohexane solution and evaporating the solvent. Next, an acidic aqueous solution of hydrochloric acid is used to leach the pore-forming agent to form a microporous wall. Leaching is carried out at room temperature and then washed with distilled water to remove acid and produce microporous walls with pores of average size from 50 angstroms to 100 microns. Example 3 A dispenser in the form of a tablet for administering procainamide hydrochloride to the gastrointestinal tract of warm-blooded animals is prepared as follows: First, 200 m9 of lightly cross-linked swellable poly(hydroxyalkyl)methacrylate are 80:20 in air suspension machine (
molecular weight 4 dissolved in methylene chloride-methanol (volume)
A composition consisting of 70% cellulose acetate with 32% acetyl content mixed with 30% polyethylene glycol 0.00 is coated to enclose the polymer.
次に、プロカインアミド塩酸塩235m9を圧縮して部
材15の形に相応する形を有する固形塊を形成させ、こ
れを粘着性液化セルロースアセテートにより部材15に
封入結合する。次に、生成する組立物を、米国特許第3
426754号の記載にならつて、0.565一0.0
75d/ダの気孔容積、0.60−0.85ダ/dの密
度および150−5000オングストロームの孔寸法を
有する微孔質重合体系ポリプロピレンの壁で取り囲む。
活性剤が薬品であるディスペンサーだけを前記したけれ
ども、農業用化学品および水処理用化学品のごときその
他の活性剤を含有する具体例も製造しうることは明白で
あろう。Next, 235 m9 of procainamide hydrochloride is compressed to form a solid mass having a shape corresponding to the shape of member 15, which is encapsulated and bonded to member 15 with adhesive liquefied cellulose acetate. The resulting assembly is then described in U.S. Pat.
Following the description in No. 426754, 0.565-0.0
Surrounded by a wall of microporous polymeric polypropylene having a pore volume of 75 d/d, a density of 0.60-0.85 d/d and a pore size of 150-5000 angstroms.
Although only dispensers have been described above in which the active agent is a chemical, it will be apparent that embodiments containing other active agents such as agricultural chemicals and water treatment chemicals may also be made.
第1図は錠剤形ディスペンサーの拡大透視図であり;第
2図は第1図のディスペンサーの作動時の部材配列を示
す断面図であり;そして第3図は第1図のディスペンサ
ーと従来技術のディスペンサーとの理論的放出速度曲線
を示すグラフである。FIG. 1 is an enlarged perspective view of the tablet-shaped dispenser; FIG. 2 is a sectional view showing the arrangement of components of the dispenser of FIG. 1 during operation; and FIG. 3 is a comparison of the dispenser of FIG. 1 and the prior art. 2 is a graph showing a theoretical release rate curve with a dispenser.
Claims (1)
あつて、壁から孔形成物質を浸出することにより形成さ
れる50オングストローム〜100ミクロンの範囲内の
孔を有する壁および隔室内に含有されている水膨潤性活
性剤組成物を含む錠剤形の拡散性活性剤ディスペンサー
であつて、上記隔室が滲透作用性溶質またはガス発生性
カップルまたは水膨潤性重合体の芯および上記芯を包ん
でいる膨張性の半透性膜からなる水の吸収に応答して膨
張する膨張性部材を含有することを特徴とする上記拡散
性活性剤ディスペンサー。1 an outer microporous wall surrounding and defining an internal compartment having pores in the range of 50 angstroms to 100 microns formed by leaching pore-forming material from the wall and within the compartment; A dispersible active agent dispenser in the form of a tablet comprising a water-swellable active agent composition contained therein, the compartment comprising a core of an osmotic solute or a gas-generating couple or a water-swellable polymer and a core of the core. A diffusible active agent dispenser as described above, comprising an expansible member that expands in response to absorption of water, comprising an encasing expansible semipermeable membrane.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6704280A JPS6048484B2 (en) | 1980-05-20 | 1980-05-20 | Diffusable activator dispenser |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6704280A JPS6048484B2 (en) | 1980-05-20 | 1980-05-20 | Diffusable activator dispenser |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5711912A JPS5711912A (en) | 1982-01-21 |
| JPS6048484B2 true JPS6048484B2 (en) | 1985-10-28 |
Family
ID=13333391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6704280A Expired JPS6048484B2 (en) | 1980-05-20 | 1980-05-20 | Diffusable activator dispenser |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6048484B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01110996U (en) * | 1988-01-19 | 1989-07-26 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH075457B2 (en) * | 1983-08-16 | 1995-01-25 | ザ ウエルカム フアウンデ−シヨン リミテツド | Pharmaceutical composition allowing the release of the active ingredient in a controlled manner |
| JPH0791184B2 (en) * | 1988-03-31 | 1995-10-04 | 田辺製薬株式会社 | Controlled release formulation and process for producing the same |
| US8282955B2 (en) | 2001-10-15 | 2012-10-09 | Ferring B.V. | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease |
| CA2501324A1 (en) * | 2002-10-30 | 2004-05-21 | Pharmacia Corporation | Oral extended release tablets and methods of making and using the same |
| CA2520197A1 (en) | 2003-04-23 | 2004-11-04 | Ferring B.V. | Sachet for a pharmaceutical composition |
| EP1547601A1 (en) | 2003-12-23 | 2005-06-29 | Ferring B.V. | Coating method |
-
1980
- 1980-05-20 JP JP6704280A patent/JPS6048484B2/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01110996U (en) * | 1988-01-19 | 1989-07-26 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5711912A (en) | 1982-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2074860A (en) | Diffusional Active Agent Dispenser | |
| US4475916A (en) | Osmotic drug delivery system | |
| EP0089548B1 (en) | Osmotic drug delivery system | |
| US4439196A (en) | Osmotic drug delivery system | |
| AU2002357930B2 (en) | Formulation & dosage form for the controlled delivery of therapeutic agents | |
| US5827538A (en) | Osmotic devices having vapor-permeable coatings | |
| US5358502A (en) | PH-triggered osmotic bursting delivery devices | |
| US4207890A (en) | Drug-dispensing device and method | |
| NL192250C (en) | Osmotic device for the controlled rate of delivery of a beneficial agent. | |
| EP0040457A2 (en) | Agent dispenser with microporous releasing diffusor | |
| JPH0155242B2 (en) | ||
| JP2006508891A (en) | Pharmaceutical composition for long-term / sustained release of therapeutically active ingredients | |
| KR20040066177A (en) | Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules | |
| JPS6244248A (en) | Dispenser for domestic animal | |
| JPS6048484B2 (en) | Diffusable activator dispenser | |
| CA1330886C (en) | Osmotic system for delivery of dilute solutions | |
| CA1128897A (en) | Diffusional active agent dispenser | |
| WO2004002448A1 (en) | Oral dosage from comprising a liquid active agent formulation andcontrolling release thereof by an expandable osmotic composition | |
| US20040062799A1 (en) | Therapeutic composition and delivery system for administering drug | |
| MXPA06001197A (en) | Osmotic engine and dosage form for controlled release of a liquid active agent formulation |